Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).

Mikhail Naum KosiborodMarilia B GomesAntonio NicolucciStuart PocockWolfgang RathmannMarina V ShestakovaHirotaka WatadaIichiro ShimomuraHungta ChenJavier Cid-RuzafaPeter FeniciNiklas HammarFilip SurmontFengming TangKamlesh Khuntinull null

Published in: Cardiovascular diabetology (2018)

The global burden of microvascular and macrovascular complications is substantial in these patients with type 2 diabetes who are relatively early in the disease process. These findings highlight an opportunity for aggressive early risk factor modification, particularly in regions with a high prevalence of complications. Trial registration ClinicalTrials.gov; NCT02322762. Registered 23 December 2014. https://clinicaltrials.gov/ct2/show/NCT02322762 . ClinicalTrials.gov; NCT02226822. Registered 27 August 2014. https://clinicaltrials.gov/ct2/show/NCT02226822.

Keyphrases

risk factors
computed tomography
image quality
dual energy
contrast enhanced
clinical trial
positron emission tomography
magnetic resonance imaging
quality improvement
phase iii
phase ii
open label